Arovella Therapeutics (ASX: ALA) is the only Australian biotech developing an iNKT cell therapy platform to create therapies for people to live longer, healthier lives. Vision: Arovella Therapeutics intends to be a world leader as a biotechnology company helping people live longer and healthier lives. Mission: We will develop our existing products and look to acquire additional platforms we believe have an impact on the treatment of cancer and conditions that affect the central nervous system.